Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology

被引:4
作者
Watanabe, Yoshitaka [1 ,2 ]
Fujinaga, Shuichiro [1 ]
Endo, Amane [3 ]
Endo, Shota [1 ]
Nakagawa, Mayu [1 ]
Sakuraya, Koji [1 ]
机构
[1] Saitama Childrens Med Ctr, Div Nephrol, Chuo Ku, 1-2 Shintoshin, Saitama, Saitama 3308777, Japan
[2] Showa Univ, Childrens Med Ctr, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan
[3] Juntendo Univ, Dept Pediat & Adolescent Med, Tokyo, Japan
关键词
Initial steroid-resistant nephrotic syndrome; Immune-based etiology; Focal segmental glomerulosclerosis; Minimal change disease; Single disease spectrum; Children; SELECTIVITY; PROTEINURIA; DISEASE;
D O I
10.1007/s00467-020-04760-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Although many pediatric nephrologists consider focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) as separate clinical entities, whether the initial histology could affect clinical courses in children with steroid-resistant nephrotic syndrome (SRNS) suspected of having an immune-based etiology remains unknown, especially for long-term outcomes. Methods We retrospectively reviewed long-term outcomes (> 3 years; median follow-up, 9.1 years) of 21 children with initial SRNS (FSGS,N = 9; MCD,N = 12) who achieved complete remission with immunosuppressive agents, including cyclosporine. Results At NS onset, incidence of acute kidney injury (67% vs. 8%,P < 0.05) and proportion of patients with non-selective proteinuria (56% vs. 0%,P < 0.01) were significantly higher in the FSGS group than the MCD group. Furthermore, median days until complete remission after treatment was significantly longer in the FSGS group than the MCD group (116 days vs. 45 days,P < 0.001). Although subsequent biopsy histology of the 12 patients in the MCD group was still identical in all MCD, three of nine patients in the FSGS group were reclassified from FSGS to MCD at second biopsy. At last visit, all patients maintained complete remission, and none developed chronic kidney disease. Conclusions Initial presentation in the FSGS group was characterized by more severe clinical manifestations than the MCD group. If complete remission is achieved, FSGS and MCD in children with immune-mediated SRNS may constitute a single disease spectrum because the long-term outcomes are favorable, irrespective of initial histology.
引用
收藏
页码:2377 / 2381
页数:5
相关论文
共 50 条
  • [21] Risks and renal outcomes of severe acute kidney injury in children with steroid-resistant nephrotic syndrome
    Sho Ishiwa
    Mai Sato
    Koichi Kamei
    Kentaro Nishi
    Toru Kanamori
    Mika Okutsu
    Masao Ogura
    Mayumi Sako
    Shuichi Ito
    Yasushi Orihashi
    Kenji Ishikura
    Clinical and Experimental Nephrology, 2022, 26 : 700 - 708
  • [22] Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
    Agnes Trautmann
    Svenja Seide
    Beata S. Lipska-Ziętkiewicz
    Fatih Ozaltin
    Maria Szczepanska
    Marta Azocar
    Augustina Jankauskiene
    Alexandra Zurowska
    Salim Caliskan
    Bassam Saeed
    William Morello
    Francesco Emma
    Mieczyslaw Litwin
    Alexey Tsygin
    Svitlana Fomina
    Anna Wasilewska
    Anette Melk
    Elisa Benetti
    Jutta Gellermann
    Natasa Stajic
    Marcin Tkaczyk
    Sergey Baiko
    Larisa Prikhodina
    Dagmar Csaicsich
    Anna Medynska
    Regina Krisam
    Heike Breitschwerdt
    Franz Schaefer
    Pediatric Nephrology, 2023, 38 : 1499 - 1511
  • [23] Management of Steroid-Resistant Nephrotic Syndrome in Children
    Sachdeva, Sanjana
    Khan, Syeda
    Davalos, Cristian
    Avanthika, Chaithanya
    Jhaveri, Sharan
    Babu, Athira
    Patterson, Daniel
    Yamani, Abdullah J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [24] Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome
    Gulati, Ashima
    Sinha, Aditi
    Gupta, Aarti
    Kanitkar, Madhuri
    Sreenivas, Vishnubhatla
    Sharma, Jyoti
    Mantan, Mukta
    Agarwal, Indira
    Dinda, Amit K.
    Hari, Pankaj
    Bagga, Arvind
    KIDNEY INTERNATIONAL, 2012, 82 (10) : 1130 - 1135
  • [25] Genetic analysis and outcomes of Omani children with steroid-resistant nephrotic syndrome
    Al Riyami, Mohamed S. S.
    Al Alawi, Intisar
    Al Gaithi, Badria
    Al Maskari, Anisa
    Al Kalbani, Naifain
    Al Hashmi, Nadia
    Al Balushi, Aisha
    Al Shahi, Maryam
    Al Saidi, Suliman
    Al Bimani, Muna
    Al Hatali, Fahad
    Mabillard, Holly
    Sayer, John A. A.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (09):
  • [26] Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome
    Li, Zhihui
    Duan, Cuirong
    He, Jinhua
    Wu, Tianhui
    Xun, Mai
    Zhang, Yi
    Yin, Yan
    PEDIATRIC NEPHROLOGY, 2010, 25 (05) : 883 - 888
  • [27] Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children
    Gulati, Sanjeev
    Prasad, Narayan
    Sharma, Raj K.
    Kumar, Alok
    Gupta, Amit
    Baburaj, Vinod P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (03) : 910 - 913
  • [28] Current understandings in treating children with steroid-resistant nephrotic syndrome
    Lee, Jiwon M.
    Kronbichler, Andreas
    Shin, Jae Il
    Oh, Jun
    PEDIATRIC NEPHROLOGY, 2021, 36 (04) : 747 - 761
  • [29] Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
    Yuko Hamasaki
    Norishige Yoshikawa
    Shinzaburo Hattori
    Satoshi Sasaki
    Kazumoto Iijima
    Koichi Nakanishi
    Takeshi Matsuyama
    Kenji Ishikura
    Nahoko Yata
    Tetsuji Kaneko
    Masataka Honda
    Pediatric Nephrology, 2009, 24 : 2177 - 2185
  • [30] Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome
    Wang, Fang
    Zhang, Yanqin
    Mao, Jianhua
    Yu, Zihua
    Yi, Zhuwen
    Yu, Li
    Sun, Jun
    Wei, Xiuxiu
    Ding, Fangrui
    Zhang, Hongwen
    Xiao, Huijie
    Yao, Yong
    Tan, Weizhen
    Lovric, Svjetlana
    Ding, Jie
    Hildebrandt, Friedhelm
    PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1181 - 1192